RICHARDSON FINANCIAL SERVICES INC.
Position in LGND — Ligand Pharmaceuticals Inc
CIK 2012303
MEDWAY, MA
Position in LGND
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$27,815
-$19,701 QoQ
Shares Held
88
-63.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#356
of 410 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RICHARDSON FINANCIAL SERVICES INC. holds $319,426 across 6 Biotechnology names. LGND ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210 | $104,313 | |
| 2 | RPRX |
Royalty Pharma plc
|
1,838 | $103,056 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
572 | $44,770 | |
| 4 | EXEL |
Exelixis, Inc.
|
715 | $38,903 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
This page
|
88 | $27,815 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
2 | $569 |
All Filings in LGND
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,815 | 88 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $47,516 | 238 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $43,107 | 228 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $37,199 | 210 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $12,845 | 113 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $8,095 | 77 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $8,250 | 77 | Shares | Sole | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||